# Randomized Controlled Clinical Study of Drug Therapy Combined With Thoracic Radiotherapy for Non-oligometastatic NSCLC

> **NCT05176067** · NA · UNKNOWN · sponsor: **Guizhou Medical University** · enrollment: 88 (estimated)

## Conditions studied

- Stage IV Non-small Cell Lung Cancer

## Interventions

- **RADIATION:** Thoracic Three-dimensional Radiotherapy

## Key facts

- **NCT ID:** NCT05176067
- **Lead sponsor:** Guizhou Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-30
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 88 (ESTIMATED)
- **Last updated:** 2022-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05176067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05176067, "Randomized Controlled Clinical Study of Drug Therapy Combined With Thoracic Radiotherapy for Non-oligometastatic NSCLC". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05176067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*